Surfactant
WHO Essential Medicine EML section: Medicines administered to the neonate
This is information only, not a prescription. Talk to a doctor or pharmacist before taking any medicine. For an overdose or poisoning, call 102.
Nepal brand names not included: no licence-safe source.
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.
None
For a suspected overdose or poisoning, call 102 now and go to the nearest emergency hospital.
Call 102What is Beractant used for?
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
What are the side effects of Beractant?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.
Who should not take Beractant?
None
What is the dose of Beractant?
Not provided here. Ask a doctor or pharmacist.
What is Beractant?
Beractant is used for: SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants. It belongs to the class: Surfactant. Common side effects include: The occurrence of concurrent illnesses common in premature infants was evaluat…
Sources: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm